PST

Serial Number 97705184
733

Registration Progress

Application Filed
Dec 6, 2022
Under Examination
Jun 13, 2023
Approved for Publication
Apr 18, 2023
Published for Opposition
Apr 18, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 4 Granted
Due: Dec 13, 2025 114 days

Trademark Image

PST

Basic Information

Serial Number
97705184
Filing Date
December 6, 2022
Published for Opposition
April 18, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
May 5, 2025
Application
Pending
Classes
001 005 042 044

Rights Holder

Adaptive Phage Therapeutics, Inc.

03
Address
708 Quince Orchard Road, Suite 205
Gaithersburg, MD 20878

Ownership History

Adaptive Phage Therapeutics, Inc.

Original Applicant
03
Gaithersburg, MD

Adaptive Phage Therapeutics, Inc.

Owner at Publication
03
Gaithersburg, MD

Legal Representation

Attorney
Leesa N. Weiss

USPTO Deadlines

Next Deadline
114 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
December 13, 2025
Extension Available
Until June 13, 2024

Application History

34 events
Date Code Type Description Documents
May 6, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 5, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 5, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
May 5, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 2, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 25, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 3, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 3, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
May 16, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 15, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 15, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 15, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 8, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 6, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 6, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 6, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 13, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 18, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 18, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 4, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 4, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 4, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 4, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 4, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 29, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 14, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 14, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 14, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 14, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 14, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 6, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 9, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 9, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
diagnostic reagents for clinical and medical laboratory use; diagnostic kits comprising diagnostic reagents for testing bacteria sensitivity, except for medical or veterinary use; human, animal, plant and microorganism biological preparations for use in industry and science, namely, for use in drug development; Biological preparations for use in industry and science, namely, for treating bacterial contamination in the fields of farming and food preparation; Biological preparations for use in industry and science, namely, for treating bacterial contamination in the industrial and food preparation fields
Class 005
human, animal, plant and microorganism biological preparations for disease modeling and personalized medicine to prevent or treat bacterial infectious diseases; bactericides, namely, biological preparations to treat bacterial infections and bacterial contamination in the field of medicine; diagnostic kits comprising medical diagnostic reagents for testing bacteria sensitivity
Class 042
new product research and development in the fields of personalized medicine and diagnostics; data mining of healthcare and genetic information in the field of precision medicine and personalized medicine; scientific study and research in the fields of biochemistry, disease, personalized medicine, personalized therapeutics, and pharmaceuticals; medical laboratory services and scientific laboratory services in the nature of clinical and medical laboratory services for medical research purposes in the fields of disease diagnostics and personalized medicine; pharmaceutical drug research and development; custom biochemical assay development; pharmaceutical drug discovery and development services; providing laboratory research services in the field of medical diagnostics and personalized medicine; medical research services; biotechnology research; providing medical and scientific research information in the field of clinical trials; new product research and development of vaccines and therapeutics; providing temporary use of online non-downloadable computer software application in the field of personalized medicine to provide medical and diagnostic services involving bacterial infections; medical research, namely, providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of bacterial infections and the analysis, evaluation and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; laboratory research in the field of genomic sequencing; research and development in the pharmaceutical and biotechnology fields; research development, engineering and testing services in the fields of bacteria and viruses; laboratory research in the field of infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; laboratory research services in the field of microbiological laboratory testing of bacteria for research purposes and technical consultation relating thereto; scientific and medical research, in particular, design and development of diagnostic assays; medical laboratory services in the nature of testing services for diagnostic purposes in the fields of disease diagnostics and personalized medicine; medical laboratory services in the nature of microbiological laboratory testing of bacteria for diagnostic and medical purposes, and technical consultation thereto
Class 044
medical testing for diagnostic or treatment purposes in the field of personalized medicine; health care services, namely, providing a database in the field of personalized medicine and featuring inputting and collection of data and information all for treatment and diagnostic purposes; medical testing for diagnostic or treatment purposes, namely, providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of bacteria infections and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; medical consulting services in the field of medical diagnostic and prognostic testing; medical services in the nature of medical analysis services for diagnostic and prognostic testing and treatment purposes; medical analysis services relating to the diagnosis and treatment of a person; medical testing and medical diagnostic services for diagnostic or treatment purposes, in particular performing tests using diagnostic assays

Classification

International Classes
001 005 042 044